BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology 2020; 31(6): 953 doi: 10.1016/j.jvir.2019.12.809
2
Roopa Rai, Jerome Deval. New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4BAntiviral Research 2011; 90(2): 93 doi: 10.1016/j.antiviral.2011.01.009
3
John Paul Pezacki, Ragunath Singaravelu, Rodney K. Lyn. Host–virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystemMolecular BioSystems 2010; 6(7): 1131 doi: 10.1039/b924668c
4
Reem Al Olaby, Hassan M. Azzazy, Rodney Harris, Brett Chromy, Jost Vielmetter, Rod Balhorn. Identification of ligands that target the HCV-E2 binding site on CD81Journal of Computer-Aided Molecular Design 2013; 27(4): 337 doi: 10.1007/s10822-013-9649-3
5
Hyock Joo Kwon, Weimei Xing, Katie Chan, Anita Niedziela-Majka, Katherine M. Brendza, Thorsten Kirschberg, Darryl Kato, John O. Link, Guofeng Cheng, Xiaohong Liu, Roman Sakowicz, Philippe A. Gallay. Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral AgentPLOS ONE 2015; 10(4): e0122844 doi: 10.1371/journal.pone.0122844
6
Howard E. Boudreau, Suzanne U. Emerson, Agnieszka Korzeniowska, Meghan A. Jendrysik, Thomas L. Leto. Hepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor β-Dependent Manner: a New Contributor to HCV-Induced Oxidative StressJournal of Virology 2009; 83(24): 12934 doi: 10.1128/JVI.01059-09
7
Gabrielle Vieyres, Thomas Pietschmann. Entry and replication of recombinant hepatitis C viruses in cell cultureMethods 2013; 59(2): 233 doi: 10.1016/j.ymeth.2012.09.005
8
Kaartik Soota, Benedict Maliakkal. Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infectionWorld Journal of Gastroenterology 2014; 20(43): 16184-16190 doi: 10.3748/wjg.v20.i43.16184
9
Nihar Shah, Tracey Pierce, Kris V Kowdley. Review of direct-acting antiviral agents for the treatment of chronic hepatitis CExpert Opinion on Investigational Drugs 2013; 22(9): 1107 doi: 10.1517/13543784.2013.806482
10
Jin-Hua Sun, Donald R. O'Boyle II, Yan Zhang, Chunfu Wang, Peter Nower, Lourdes Valera, Susan Roberts, Richard E. Nettles, Robert A. Fridell, Min Gao. Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052Hepatology 2012; 55(6): 1692 doi: 10.1002/hep.25581
11
Ryota Masuzaki, Tatsuo Kanda, Haruhiko Yoshida, Naoya Kato, Masao Omata. Hepatocellular Carcinoma2016; : 261 doi: 10.1007/978-3-319-34214-6_17
12
V. E. Gurtsevitch. Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesisBiochemistry (Moscow) 2008; 73(5): 504 doi: 10.1134/S0006297908050039
13
Cristina Simona Strahotin, Michael Babich. Hepatitis C Variability, Patterns of Resistance, and Impact on TherapyAdvances in Virology 2012; 2012: 1 doi: 10.1155/2012/267483
14
Ming-Ju Hsieh, Kuang-Ping Lan, Hao-Yu Liu, Xiao-Zong Zhang, Yaw-Feng Lin, Tzy-Yen Chen, Hui-Ling Chiou. Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytesBMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-74
15
Mustafa Altindis, Tuba Dal, Isin Akyar, Onur Karatuna, Selma Gokahmetoglu, Seda Tezcan Ulger, Canan Kulah, Berrin Uzun, Aslı Gamze Şener, Mehmet Ozdemir, Sibel Aydogan, Mert Ahmet Kuskucu, Kenan Midilli, Baris Otlu, Mustafa Kemal Celen, Kurtulus Buruk, Huseyin Guducuoglu. Six-year distribution pattern of hepatitis C virus in Turkey: a multicentre studyBiotechnology & Biotechnological Equipment 2016; 30(2): 335 doi: 10.1080/13102818.2015.1093430
16
Lokesh P. Tripathi, Chikako Kataoka, Shuhei Taguwa, Kohji Moriishi, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Network based analysis of hepatitis C virus Core and NS4B protein interactionsMolecular BioSystems 2010; 6(12): 2539 doi: 10.1039/c0mb00103a
17
Clinical Cases in Dental Hygiene2018; : 75 doi: 10.1002/9781119461067.ch3
18
Iman Jamhiri, Khashayar Shahin, Zahra Khodabandeh, Kurosh Kalantar, Jamal Sarvari, Amir Atapour, Fatemeh Mina, Asma Ahmadnejad, Seyed Younes Hosseini. Recombinant NS3 Protein Induced Expression of Immune Modulatory Elements in Hepatic Stellate Cells During Its Fibrotic ActivityViral Immunology 2018; 31(8): 575 doi: 10.1089/vim.2018.0018
19
Sergey A. Shiryaev, Elliot R. Thomsen, Piotr Cieplak, Eugene Chudin, Anton V. Cheltsov, Mark S. Chee, Igor A. Kozlov, Alex Y. Strongin, Tianyi Wang. New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage AssayPLoS ONE 2012; 7(4): e35759 doi: 10.1371/journal.pone.0035759
20
Feng He, Sangeeta B. Joshi, Fons Bosman, Marijke Verhaeghe, C. Russell Middaugh. Structural stability of hepatitis C virus envelope glycoprotein E1: Effect of pH and dissociative detergentsJournal of Pharmaceutical Sciences 2009; 98(9): 3340 doi: 10.1002/jps.21657
21
B. Wen, Y. Deng, J. Guan, W. Yan, Y. Wang, W. Tan, J. Gao. Signal peptide replacements enhance expression and secretion of hepatitis C virus envelope glycoproteinsActa Biochimica et Biophysica Sinica 2011; 43(2): 96 doi: 10.1093/abbs/gmq117
22
Lokesh P. Tripathi, Hiroto Kambara, Yi-An Chen, Yorihiro Nishimura, Kohji Moriishi, Toru Okamoto, Eiji Morita, Takayuki Abe, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Understanding the Biological Context of NS5A–Host Interactions in HCV Infection: A Network-Based ApproachJournal of Proteome Research 2013; 12(6): 2537 doi: 10.1021/pr3011217
23
Jacqueline G. O’Leary, Gary L. Davis. Sleisenger and Fordtran's Gastrointestinal and Liver Disease2010; : 1313 doi: 10.1016/B978-1-4160-6189-2.00079-2
24
Ramesh Kakarla, Jian Liu, Devan Naduthambi, Wonsuk Chang, Ralph T. Mosley, Donghui Bao, Holly M. Micolochick Steuer, Meg Keilman, Shalini Bansal, Angela M. Lam, William Seibel, Sandra Neilson, Phillip A. Furman, Michael J. Sofia. Discovery of a Novel Class of Potent HCV NS4B Inhibitors: SAR Studies on Piperazinone DerivativesJournal of Medicinal Chemistry 2014; 57(5): 2136 doi: 10.1021/jm4012643
25
Fernando González-Candelas, F Xavier López-Labrador. Clinical relevance of genetic heterogeneity in HCVFuture Virology 2010; 5(1): 33 doi: 10.2217/fvl.09.63
26
Sarah Welbourn, Arnim Pause. HCV NS2/3 protease: a future antiviral drug target?Future Virology 2009; 4(5): 463 doi: 10.2217/fvl.09.29
27
Michael A. Nalesnik, Tatsuya Kanto. Natural Killer Cells2010; : 571 doi: 10.1016/B978-0-12-370454-2.00044-2
28
B. J. Thomson. Hepatitis C virus: the growing challengeBritish Medical Bulletin 2008; 89(1): 153 doi: 10.1093/bmb/ldp003
29
Irene Boo, Kevin teWierik, Florian Douam, Dimitri Lavillette, Pantelis Poumbourios, Heidi E. Drummer. Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2Biochemical Journal 2012; 443(1): 85 doi: 10.1042/BJ20110868
30
Ryota Masuzaki, Haruhiko Yoshida, Naoya Kato, Masao Omata. Hepatocellular Carcinoma2009; : 259 doi: 10.1007/978-1-60327-376-3_8
31
Brendan A. Palmer, Liam J. Fanning, Tamir Tuller. Synonymous Co-Variation across the E1/E2 Gene Junction of Hepatitis C Virus Defines Virion FitnessPLOS ONE 2016; 11(11): e0167089 doi: 10.1371/journal.pone.0167089
32
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular CarcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53051-2
33
Arthi Venkatesan, Febin Prabhu Dass J.. Review on chemogenomic approaches towards hepatitis C viral targetsJournal of Cellular Biochemistry 2019; 120(8): 12167 doi: 10.1002/jcb.28581
34
Gustavo Tavares Ventura, Emmerson Corrêa Brasil da Costa, Anne Miranda Capaccia, Ronaldo Mohana-Borges, Xi Zhou. pH-Dependent Conformational Changes in the HCV NS3 Protein Modulate Its ATPase and Helicase ActivitiesPLoS ONE 2014; 9(12): e115941 doi: 10.1371/journal.pone.0115941
35
M. Dominguez-Villar, F. J. Garcia-Cozar, B. J. Chambers. The Effects of Hepatitis C Virus Core Protein on Functional Responses in the NK Cell Line YTSScandinavian Journal of Immunology 2012; 75(1): 54 doi: 10.1111/j.1365-3083.2011.02624.x
36
Sara Abouelasrar Salama, Mieke Gouwy, Alexandra De Zutter, Noëmie Pörtner, Lotte Vanbrabant, Nele Berghmans, Mieke De Buck, Sofie Struyf, Jo Van Damme. Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1β and Interferon-γ in Liver Bystander CellsJournal of Interferon & Cytokine Research 2020; 40(4): 195 doi: 10.1089/jir.2019.0115
37
Xiaohong Hou, Wengang Yang, Yongsen Zhao, Atul Agarwal, Mingjun Huang. Internal cleavages of hepatitis C virus NS3 induced by P1 mutations at the NS3/4A cleavage siteVirology 2009; 383(2): 271 doi: 10.1016/j.virol.2008.10.037
38
Yun Sik Hwang, Byeong Joo Jun, Tae Seon Yoon. Analysis of HCV’s Linearity Using Support Vector Machine (SVM)Applied Mechanics and Materials 2014; : 1265 doi: 10.4028/www.scientific.net/AMM.548-549.1265
39
Raewyn M. Poole. Daclatasvir + Asunaprevir: First Global ApprovalDrugs 2014; 74(13): 1559 doi: 10.1007/s40265-014-0279-4
40
Lei Shi, Shu-lin Zhang, Kang Li, Yuan Hong, Qi Wang, Yue Li, Jiang Guo, Wan-hu Fan, Lei Zhang, Jun Cheng. NS5ATP9, a gene up-regulated by HCV NS5A proteinCancer Letters 2008; 259(2): 192 doi: 10.1016/j.canlet.2007.10.029
41
Zhengkun Tu, Robert H. Pierce, Jonathan Kurtis, Yoshio Kuroki, I. Nicholas Crispe, Mark S. Orloff. Hepatitis C Virus Core Protein Subverts the Antiviral Activities of Human Kupffer CellsGastroenterology 2010; 138(1): 305 doi: 10.1053/j.gastro.2009.09.009
42
Gyongyi Szabo, Angela Dolganiuc. Hepatitis C core protein – The “core” of immune deception?Journal of Hepatology 2008; 48(1): 8 doi: 10.1016/j.jhep.2007.10.005
43
M Carrozzo. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphomaOral Diseases 2008; 14(2): 123 doi: 10.1111/j.1601-0825.2007.01436.x
44
Jillian Whidby, Guaniri Mateu, Hannah Scarborough, Borries Demeler, Arash Grakoui, Joseph Marcotrigiano. Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 EctodomainJournal of Virology 2009; 83(21): 11078 doi: 10.1128/JVI.00800-09
45
Alessia Bianchi, Stefania Crotta, Michela Brazzoli, Steven K. H. Foung, Marcello Merola. Hepatitis C Virus E2 Protein Ectodomain Is Essential for Assembly of Infectious VirionsInternational Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/968161
46
Małgorzata Rychłowska, Ania M. Owsianka, Steven K. H. Foung, Jean Dubuisson, Krystyna Bieńkowska-Szewczyk, Arvind H. Patel. Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure–function relationships Journal of General Virology 2011; 92(10): 2249 doi: 10.1099/vir.0.034314-0
47
Mireille Baltzinger, Kamal Kant Sharma, Yves Mély, Danièle Altschuh. Dissecting the oligonucleotide binding properties of a disordered chaperone protein using surface plasmon resonanceNucleic Acids Research 2013; 41(22): 10414 doi: 10.1093/nar/gkt792
48
Qiaoling Gong, Min Cheng, Hui Chen, Xiuying Liu, Youhui Si, Yang Yang, Yanzhi Yuan, Chaozhi Jin, Wei Yang, Fuchu He, Jian Wang. Phospholipid scramblase 1 mediates hepatitis C virus entry into host cellsFEBS Letters 2011; 585(17): 2647 doi: 10.1016/j.febslet.2011.07.019
49
Chul Hyun Joo, Uk Lee, Young Ran Nam, Jae U. Jung, Heuiran Lee, Young Keol Cho, Yoo Kyum Kim. Gene Therapeutic Approach for Inhibiting Hepatitis C Virus Replication Using a Recombinant Protein That Controls Interferon ExpressionAntimicrobial Agents and Chemotherapy 2010; 54(12): 5048 doi: 10.1128/AAC.00682-10
50
Xiao Fan, Bin Xue, Patrick T. Dolan, Douglas J. LaCount, Lukasz Kurgan, Vladimir N. Uversky. The intrinsic disorder status of the human hepatitis C virus proteomeMol. BioSyst. 2014; 10(6): 1345 doi: 10.1039/C4MB00027G
51
Corlan O Adebajo, Nancy Reau. Overtreating versus undertreating: what is the optimized treatment duration in HCV?Future Virology 2015; 10(9): 1049 doi: 10.2217/fvl.15.71
52
Dennis Özcelik, Andrew Seto, Bojana Rakic, Ali Farzam, Frantisek Supek, John Paul Pezacki. Gene Expression Profiling of Endoplasmic Reticulum Stress in Hepatitis C Virus-Containing Cells Treated with an Inhibitor of Protein Disulfide IsomerasesACS Omega 2018; 3(12): 17227 doi: 10.1021/acsomega.8b02676
53
Xiaoli Pang, Zhaoxia Wang, Naicui Zhai, Qianqian Zhang, Hongxiao Song, Yujiao Zhang, Tianyang Li, Haijun Li, Lishan Su, Junqi Niu, Zhengkun Tu. IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid:polycytodylic acidInternational Immunopharmacology 2016; 38: 284 doi: 10.1016/j.intimp.2016.06.013
54
Regina Maria Santos de Amorim, Alexandre Coelho, Elisabeth Lampe, Tainá Raiol, Regina Maria Bringel Martins. Genetic diversity of hepatitis C virus quasispecies in chronic renal failure patients in Midwest BrazilArchives of Virology 2014; 159(8): 1917 doi: 10.1007/s00705-014-1994-6
55
Markus Reiser, Jörg Timm. Serine protease inhibitors as anti-hepatitis C virus agentsExpert Review of Anti-infective Therapy 2009; 7(5): 537 doi: 10.1586/eri.09.30
56
Jacqueline G. O'Leary, Gary L. Davis. Review: Hepatitis C virus replication and potential targets for direct-acting agentsTherapeutic Advances in Gastroenterology 2010; 3(1): 43 doi: 10.1177/1756283X09353353
57
John B. Patton, David George, Kyeong-Ok Chang. Bile Acids Promote HCV Replication through the EGFR/ERK Pathway in Replicon-Harboring CellsIntervirology 2011; 54(6): 339 doi: 10.1159/000321452
58
Lucie Goueslain, Khaled Alsaleh, Pauline Horellou, Philippe Roingeard, Véronique Descamps, Gilles Duverlie, Yann Ciczora, Czeslaw Wychowski, Jean Dubuisson, Yves Rouillé. Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA ReplicationJournal of Virology 2010; 84(2): 773 doi: 10.1128/JVI.01190-09
59
Martin Coenen, Hans Dieter Nischalke, Benjamin Krämer, Bettina Langhans, Andreas Glässner, Daniela Schulte, Christian Körner, Tilman Sauerbruch, Jacob Nattermann, Ulrich Spengler. Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2Laboratory Investigation 2011; 91(9): 1375 doi: 10.1038/labinvest.2011.78
60
Samuel K. Kwofie, Ulf Schaefer, Vijayaraghava S. Sundararajan, Vladimir B. Bajic, Alan Christoffels. HCVpro: Hepatitis C virus protein interaction databaseInfection, Genetics and Evolution 2011; 11(8): 1971 doi: 10.1016/j.meegid.2011.09.001
61
Roberta Spadaccini, Gerardino D'Errico, Viviana D'Alessio, Eugenio Notomista, Alessia Bianchi, Marcello Merola, Delia Picone. Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoproteinBiochimica et Biophysica Acta (BBA) - Biomembranes 2010; 1798(3): 344 doi: 10.1016/j.bbamem.2009.10.018
62
Feng Ni, Smitha Kota, Virginia Takahashi, A. Donny Strosberg, John K. Snyder. Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agentsBioorganic & Medicinal Chemistry Letters 2011; 21(8): 2198 doi: 10.1016/j.bmcl.2011.03.014
63
Weifeng Shi, Ines T. Freitas, Chaodong Zhu, Wei Zheng, William W. Hall, Desmond G. Higgins, John E. Tavis. Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype RecombinantsPLoS ONE 2012; 7(7): e41997 doi: 10.1371/journal.pone.0041997
64
Sergey A. Shiryaev, Andrei V. Chernov, Tatiana N. Shiryaeva, Alexander E. Aleshin, Alex Y. Strongin. The acidic sequence of the NS4A cofactor regulates ATP hydrolysis by the HCV NS3 helicaseArchives of Virology 2011; 156(2): 313 doi: 10.1007/s00705-010-0838-2
65
Morgan M. Martin, Stephanie A. Condotta, Jeremy Fenn, Andrea D. Olmstead, François Jean. In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profileBiological Chemistry 2011; 392(10): 927 doi: 10.1515/BC.2011.076
66
Flavia Bernini, Erika Ebranati, Chiara De Maddalena, Renata Shkjezi, Laura Milazzo, Alessandra Lo Presti, Massimo Ciccozzi, Massimo Galli, Gianguglielmo Zehender, John Tavis. Within-Host Dynamics of the Hepatitis C Virus Quasispecies Population in HIV-1/HCV Coinfected PatientsPLoS ONE 2011; 6(1): e16551 doi: 10.1371/journal.pone.0016551
67
Developments in the HCV Screening Technologies Based on the Detection of Antigens and AntibodiesSensors 2019; 19(19): 4257 doi: 10.3390/s19194257
68
Christopher J. Mee, Michelle J. Farquhar, Helen J. Harris, Ke Hu, Wenda Ramma, Asif Ahmed, Patrick Maurel, Roy Bicknell, Peter Balfe, Jane A. McKeating. Hepatitis C Virus Infection Reduces Hepatocellular Polarity in a Vascular Endothelial Growth Factor–Dependent MannerGastroenterology 2010; 138(3): 1134 doi: 10.1053/j.gastro.2009.11.047
69
Catherine Fauvelle, Quentin Lepiller, Daniel J. Felmlee, Isabel Fofana, François Habersetzer, Françoise Stoll-Keller, Thomas F. Baumert, Samira Fafi-Kremer. Hepatitis C virus vaccines – Progress and perspectivesMicrobial Pathogenesis 2013; 58: 66 doi: 10.1016/j.micpath.2013.02.005
70
Maemu Petronella Gededzha, M. Jeffrey Mphahlele, Jason T. Blackard, Selokela Gloria Selabe. Prevalence of NS5B Resistance Mutations in Hepatitis C Virus (HCV) Treatment Naive South AfricansHepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.14248
71
Arthur Donny Strosberg, Smitha Kota, Virginia Takahashi, John K. Snyder, Guillaume Mousseau. Core as a Novel Viral Target for Hepatitis C DrugsViruses 2010; 2(8): 1734 doi: 10.3390/v2081734
72
F. Poordad, D. Dieterich. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agentsJournal of Viral Hepatitis 2012; 19(7): 449 doi: 10.1111/j.1365-2893.2012.01617.x
73
Ulrike Breitinger, Noha S. Farag, Nourhan K.M. Ali, Hans-Georg A. Breitinger. Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to InhibitorsBiophysical Journal 2016; 110(11): 2419 doi: 10.1016/j.bpj.2016.04.018
74
Tomohiko Maehama, Masayoshi Fukasawa, Tomoko Date, Takaji Wakita, Kentaro Hanada. A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replicationBiochemical and Biophysical Research Communications 2013; 440(1): 150 doi: 10.1016/j.bbrc.2013.09.048
75
Anoop Kumar, Roma Pandey, Inderjit S. Yadav, Mausumi Bharadwaj. Structural and Epitope Analysis (T- and B-Cell Epitopes) of Hepatitis C Virus (HCV) Glycoproteins: An in silico ApproachJournal of Clinical and Experimental Hepatology 2018; 8(4): 352 doi: 10.1016/j.jceh.2017.12.010
76
Eve-Isabelle Pécheur. Lipoprotein Receptors and Lipid Enzymes in Hepatitis C Virus Entry and Early Steps of InfectionScientifica 2012; 2012: 1 doi: 10.6064/2012/709853
77
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert. Mouse models for the study of HCV infection and virus–host interactionsJournal of Hepatology 2008; 49(1): 134 doi: 10.1016/j.jhep.2008.03.012
78
John Carl Hoefs, Vikramjit S. Aulakh, Bernard Joseph Ilagan. Very Low Viral Load (VLVL) Relapse Following Treatment of Naïve Patients with Chronic Hepatitis CDigestive Diseases and Sciences 2012; 57(1): 243 doi: 10.1007/s10620-011-1973-7
79
Giuseppe A Sautto, Karin Wisskirchen, Nicola Clementi, Matteo Castelli, Roberta A Diotti, Julia Graf, Massimo Clementi, Roberto Burioni, Ulrike Protzer, Nicasio Mancini. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoproteinGut 2016; 65(3): 512 doi: 10.1136/gutjnl-2014-308316
80
Dae-Sun Kim, Young-Joo Cho, Byoung-Guk Kim, Su-Hae Lee, Jae-Hwan Nam. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vectorVaccine 2010; 28(5): 1234 doi: 10.1016/j.vaccine.2009.11.017
81
Konstantina Katsarou, Panagiota Tsitoura, Urania Georgopoulou. MEK5/ERK5/mef2: A novel signaling pathway affected by hepatitis C virus non-enveloped capsid-like particlesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011; 1813(10): 1854 doi: 10.1016/j.bbamcr.2011.06.015
82
Andrew H. Talal, Yang Chen, Marija Zeremski, Roberto Zavala, Clewert Sylvester, Mary Kuhns, Lawrence S. Brown, Marianthi Markatou, Gavin A. Cloherty. Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disordersJournal of Substance Abuse Treatment 2017; 78: 37 doi: 10.1016/j.jsat.2017.04.011
83
Zhiyan Yao, Xiaotian Song, Shiru Cao, Wenzhang Liang, Wenran Lu, Lijuan Yang, Zhengzheng Zhang, Lin Wei, Ratna B. Ray. Role of the Exogenous HCV Core Protein in the Interaction of Human Hepatocyte Proliferation and Macrophage Sub-PopulationsPLoS ONE 2014; 9(9): e108278 doi: 10.1371/journal.pone.0108278
84
Lokesh P. Tripathi, Hiroto Kambara, Kohji Moriishi, Eiji Morita, Takayuki Abe, Yoshio Mori, Yi-An Chen, Yoshiharu Matsuura, Kenji Mizuguchi. Proteomic Analysis of Hepatitis C Virus (HCV) Core Protein Transfection and Host Regulator PA28γ Knockout in HCV Pathogenesis: A Network-Based StudyJournal of Proteome Research 2012; 11(7): 3664 doi: 10.1021/pr300121a
85
Narotam Narotam. Characterization of Hepatitis C Virus (HCV) Genotypes with Spectrum of its Viral LoadJournal of Analytical & Pharmaceutical Research 2016; 3(3) doi: 10.15406/japlr.2016.03.00058